Treatment of Recurrent Herpes Simplex Labialis with Levamisole
Because deficient immune responses may play a contributory role in recurrent herpes simplex labialis, an immunomodulating agent, levamisole, has been advocated for therapy. Forty-two patients with a high frequency of recurrent herpes simplex labialis were followed for a mean of 7.8 months (range 4 t...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1979
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352734/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/525982/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.15.5.662 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|